SCHEMBL4693005

SCHEMBL4693005

N=C(N)Nc1ncnc2cc(O)ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 8/20 0.50
GLA P06280 1/20 0.41
HTT P42858 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
GAA P10253 1/20 0.40
RET P07949 5/20 0.39
KDR P35968 5/20 0.39
ALK Q9UM73 2/20 0.39
GAK O14976 1/20 0.39
RIPK2 O43353 1/20 0.39
STK10 O94804 1/20 0.39
FLT3 P36888 1/20 0.39
JAK3 P52333 1/20 0.39
AAK1 Q2M2I8 1/20 0.39
Q6ZSR9 Q6ZSR9 1/20 0.39
SLK Q9H2G2 1/20 0.39
IRAK4 Q9NWZ3 1/20 0.39
RPS6KA6 Q9UK32 1/20 0.39
KIF5B P33176 4/20 0.39
LCK P06239 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4751092 0.79 ADORA3 (0.56) EGFRGLAHTTABCG2GAA
SCHEMBL1707023 0.73 HTT (0.56) EGFRGLAHTTABCG2GAA
SCHEMBL28748550 0.72 EGFR (0.72) EGFRGLAHTTABCG2GAA
SCHEMBL4431055 0.71 MAP4K4 (0.54) EGFRESR1ESR2
SCHEMBL5453911 0.70 EGFR (0.46) EGFRGLAHTTABCG2RET
SCHEMBL20813449 0.67 EGFR (0.44) EGFRGLAHTTABCG2RET
SCHEMBL5465224 0.67 PDE4A (0.53) EGFRHTTGAARETKDR
SCHEMBL8871490 0.67 EGFR (0.72) EGFRGLAHTTRETKDR
SCHEMBL1439251 0.66 EGFR (0.61) EGFRBRAFADORA3
SCHEMBL22164672 0.65 EGFR (0.49) EGFRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-7001904-B1 Guanidine derivatives quinazoline and quinoline for use in the treatment of autoimmune diseases ASTRAZENECA AB (SE) 2006-02-21 US disclosed
EP-1296973-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES AstraZeneca AB (SE) 2003-04-02 EP disclosed
WO-2002000644-A1 GUANIDINE DERIVATIVES OF QUINAZOLINE AND QUINOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2002-01-03 WO disclosed